IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
EGYPT
HEXAL
Full Name: Hexal Egypt S.A.E.
Street Ad dress: 51 Bei rut Street, Heliopolis,
Cairo
Tel: +20 2 6907017
Fax: +20 2 6907019
Home Page: www.sandoz.com.eg
Con tacts (Pharm): Chair man: Sany Issa
NOVARTIS
Full Name: Novartis Pharma S.A.E.
Postal Ad dress: PO Box 1893, Cairo 11511
Street Ad dress: El Sawah St, Amiria, Cairo
11511
Tel: +20 2 2593990
Fax: +20 2 4505345
Home Page: www.mea.novartis.com
De scrip tion: Re searcher, man u fac turer,
packager/as sem bler, im porter, dis trib u tor, pro -
moter, sales/detailer. Man u fac tures for other
com pa nies. Prod uct ranges in clude: phar ma ceu ti -
cal prod ucts (branded, unbranded, pre scrip tion,
non-pre scrip tion), oph thal mic prod ucts. Es tab -
lished 1997. 367 phar ma ceu ti cal em ploy ees in
2005. Di vi sions in clude: Novartis Pharma.
Pharmaceuticals; Con sumer Health; Generics;
Ciba Vision; Sandoz.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 101-500 (2005)
Con tacts (Pharm): Chair man: Hansjuergen
Beger; Com mer cial Op er a tions: Frederic
Guerard; Man u fac ture: Alaa Nashaat; Mar ket Re -
search: Walid Saafan; Re search & De vel op ment:
S. El Sharkway
Sub sid iary of: Novartis, Swit zer land (99%)
Phar ma ceu ti cal Sales: US$ 60-65 mil lion
Prod ucts (% of Sales by Lead ing 5): 50-55%
Ther a peu tic Classes (% of Sales by Lead ing
5): 75-80%
Dose Forms (% of Sales by Lead ing 5):
85-90%
Prin ci pal Prod ucts:
CATAFLAM (antirheumatic non-steroidal)
VOLTAREN (antirheumatic non-steroidal)
TEGRETOL (antiepileptic)
FORADIL (B2-stim u lant)
CATAFAST (antirheumatic non-steroidal)
Ther a peu tic Range:
anti rheu ma tics sys temic 41%
antiepileptics 12%
renin-an gio ten sin sys tem agents 11%
antiasthma and COPD prod ucts 8%
gynecologicals other 6%
Lead ing Dose Forms:
tab lets 26%
coated tab lets 25%
am poules 19%
cap sules 14%
pow ders/gran ules 5%
NOVARTIS CON SUMER HEALTH
Full Name: Novartis Egypt (Healthcare) S.A.E.
Street Ad dress: 12 El Rabiee Street, (of Ahmed
Hosny Street), 1st Zone, Nasr City, Cairo 11511
Tel: +20 2 4052180
Fax: +20 2 4052184
Email: nch.egypt@novartis.com
Home Page:
www.consumerhealth.eg.novartis.com
De scrip tion: De vel oper, man u fac turer,
packager/as sem bler, im porter, ex porter, dis trib -
u tor, pro moter, sales/detailer. Packs/as sem bles,
im ports, ex ports, dis trib utes for other com pa nies.
Prod uct ranges in clude: phar ma ceu ti cal prod ucts
(branded, pre scrip tion, non-pre scrip tion), di -
etetic/nu tri tional prod ucts, herbal products,
medical supplies.
Con tacts (Pharm): Chair man: Ali Ghamraioy
Sub sid iary of: Novartis, Swit zer land (96%)
Phar ma ceu ti cal Sales: US$ 14-16 mil lion
Prod ucts (% of Sales by Lead ing 5): 65-70%
Ther a peu tic Classes (% of Sales by Lead ing
5): 70-75%
Dose Forms (% of Sales by Lead ing 5):
90-95%
Prin ci pal Prod ucts:
OTRIVIN (na sal prep a ra tion top i cal)
SPASMO CANULASE D (di ges tive in clud ing en -
zymes)
VOLTAREN C.H. (antirheumatic top i cal;
antirheumatic non-steroidal)
BRADORAL (throat prep a ra tion)
FENISTIL (an ti his ta mine sys temic; antipruritic)
Ther a peu tic Range:
na sal prep a ra tions 20%
di ges tives in clud ing di ges tive en zymes 16%
anti rheu ma tics top i cal 13%
throat prep a ra tions 13%
an ti his ta mines sys temic 12%
Lead ing Dose Forms:
liq uids 29%
coated tab lets 27%
gels/sols 16%
© 2009 IMS Health In cor po rated or its af fil i ates Page 165